Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:53 UTC |
---|
HMDB ID | HMDB0015178 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Gatifloxacin |
---|
Description | Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces an eye-drop formulation called Zymar. Gatifloxacin is available as tablets and in various aqueous solutions for intravenous therapy. [Wikipedia ] |
---|
Structure | COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1 InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26) |
---|
Synonyms | Value | Source |
---|
1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid | ChEBI | 1-Cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid | ChEBI | AM 1155 | ChEBI | Gatifloxacine | ChEBI | Gatifloxacino | ChEBI | Gatifloxacinum | ChEBI | Gatifloxacin anhydrous | Kegg | Zymer | Kegg | 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylate | Generator | 1-Cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylate | Generator | Tequin | MeSH | Zymar | MeSH |
|
---|
Chemical Formula | C19H22FN3O4 |
---|
Average Molecular Weight | 375.3941 |
---|
Monoisotopic Molecular Weight | 375.159434412 |
---|
IUPAC Name | 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
---|
Traditional Name | gatifloxacin |
---|
CAS Registry Number | 112811-59-3 |
---|
SMILES | COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1 |
---|
InChI Identifier | InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26) |
---|
InChI Key | XUBOMFCQGDBHNK-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Quinoline carboxylic acids |
---|
Direct Parent | Quinoline carboxylic acids |
---|
Alternative Parents | |
---|
Substituents | - Quinoline-3-carboxylic acid
- Fluoroquinolone
- N-arylpiperazine
- Aminoquinoline
- Haloquinoline
- Dihydroquinolone
- Dihydroquinoline
- Pyridine carboxylic acid or derivatives
- Pyridine carboxylic acid
- Methoxyaniline
- Anisole
- Dialkylarylamine
- Tertiary aliphatic/aromatic amine
- Alkyl aryl ether
- Piperazine
- Benzenoid
- 1,4-diazinane
- Aryl halide
- Pyridine
- Aryl fluoride
- Heteroaromatic compound
- Vinylogous amide
- Tertiary amine
- Amino acid or derivatives
- Amino acid
- Secondary amine
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Azacycle
- Carboxylic acid
- Ether
- Secondary aliphatic amine
- Organooxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Amine
- Organohalogen compound
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organofluoride
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 182 - 185 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.63 g/L | Not Available | LogP | 2.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Gatifloxacin,1TMS,isomer #1 | COC1=C(N2CCNC(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C)C2=O | 3325.2 | Semi standard non polar | 33892256 | Gatifloxacin,1TMS,isomer #2 | COC1=C(N2CCN([Si](C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O)C2=O | 3347.1 | Semi standard non polar | 33892256 | Gatifloxacin,2TMS,isomer #1 | COC1=C(N2CCN([Si](C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C)C2=O | 3282.9 | Semi standard non polar | 33892256 | Gatifloxacin,2TMS,isomer #1 | COC1=C(N2CCN([Si](C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C)C2=O | 3119.6 | Standard non polar | 33892256 | Gatifloxacin,2TMS,isomer #1 | COC1=C(N2CCN([Si](C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C)C2=O | 3760.2 | Standard polar | 33892256 | Gatifloxacin,1TBDMS,isomer #1 | COC1=C(N2CCNC(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C(C)(C)C)C2=O | 3478.8 | Semi standard non polar | 33892256 | Gatifloxacin,1TBDMS,isomer #2 | COC1=C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O)C2=O | 3571.5 | Semi standard non polar | 33892256 | Gatifloxacin,2TBDMS,isomer #1 | COC1=C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C(C)(C)C)C2=O | 3643.7 | Semi standard non polar | 33892256 | Gatifloxacin,2TBDMS,isomer #1 | COC1=C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C(C)(C)C)C2=O | 3513.3 | Standard non polar | 33892256 | Gatifloxacin,2TBDMS,isomer #1 | COC1=C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)C(F)=CC2=C1N(C1CC1)C=C(C(=O)O[Si](C)(C)C(C)(C)C)C2=O | 3921.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Gatifloxacin GC-MS (Non-derivatized) - 70eV, Positive | splash10-03di-1009000000-78a39452af06b1f66c1d | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Gatifloxacin GC-MS (1 TMS) - 70eV, Positive | splash10-001i-2003900000-7300cb8bf451e3a14f81 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Gatifloxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Gatifloxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Gatifloxacin GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Gatifloxacin GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Gatifloxacin GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Gatifloxacin DI-ESI-qTof , Negative-QTOF | splash10-0159-0019000000-9d9810e16459120201fc | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Gatifloxacin LC-ESI-qTof , Positive-QTOF | splash10-00kr-0942000000-432aa78e495cb764bf6a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Gatifloxacin LC-ESI-qTof , Positive-QTOF | splash10-000i-0922000000-8e80b2969083df9af733 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Gatifloxacin , positive-QTOF | splash10-004i-0169000000-7839341ea49cae9ec8cd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Gatifloxacin , positive-QTOF | splash10-000i-0922000000-8e80b2969083df9af733 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Gatifloxacin , positive-QTOF | splash10-004i-0279000000-0ee0061b508877e5251c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Gatifloxacin , positive-QTOF | splash10-00kr-0942000000-432aa78e495cb764bf6a | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 10V, Positive-QTOF | splash10-004i-0009000000-febde21288cfd8b65bba | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 20V, Positive-QTOF | splash10-000x-5009000000-2bb94673281db9c71250 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 40V, Positive-QTOF | splash10-0006-9012000000-ebdcd48decdc15ee504a | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 10V, Negative-QTOF | splash10-0089-0009000000-97fc4892888449eada82 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 20V, Negative-QTOF | splash10-0gwb-0039000000-0c4c3d30828e5db88fd6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 40V, Negative-QTOF | splash10-0a59-9053000000-4d294aabf5e9cb6ea3b2 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 10V, Positive-QTOF | splash10-056r-0009000000-cba07e04dae1eba32c79 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 20V, Positive-QTOF | splash10-0a4i-0009000000-3085d1f976b6e0a52538 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 40V, Positive-QTOF | splash10-05tf-3159000000-79cc5ce3bdd0230c2838 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 10V, Negative-QTOF | splash10-00e9-0009000000-8f66bae3e284a8e7f018 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 20V, Negative-QTOF | splash10-03di-0029000000-750db431dd4870d399aa | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Gatifloxacin 40V, Negative-QTOF | splash10-00ri-0197000000-0b9db2d8ea5a518c1b83 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|